Fennec Pharmaceuticals (FENC) Misses Q3 EPS by 9c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q3 EPS of ($0.02), $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.37 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
• Increasing unusual option volume: DOMO XLI BMNU VERA TENX ARKG THC FROG SNDU PEP
• 2026 Provider EHR IT Consulting Benchmark as Health Systems Shift from Replacement-Led Projects to Optimization, Workflow Redesign and Measurable Installed-Base Value